XpresSpa (Nasdaq: XSPA) shares are trading sharply higher on Friday after the company announced it signed a contract to screen and test for COVID-19 at JFK International Air Terminal. The terminal will host nine separate testing rooms with a capacity to administer over 500 tests per day. XpresSpa says it will offer its services to airline employees, contractors and workers, concessionaires and their employees, TSA officers, and U.S. Customs and…
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over